Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
November 14 2016 - 11:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
SEC FILE NUMBER
001 – 37940
NOTIFICATION OF LATE FILING
CUSIP NUMBER
67052F102
(Check One):
☐
Form 10-K ☐ Form 20-F ☐ Form 11-K
☒
Form 10-Q ☐ Form 10-D ☐ Form N-SAR
☐ Form N-CSR
For Period Ended:
September 30, 2016
☐
|
Transition Report on Form 10-K
|
☐
|
Transition Report on Form 20-F
|
☐
|
Transition Report on Form 11-K
|
☐
|
Transition Report on Form 10-Q
|
☐
|
Transition Report on Form N-SAR
|
For the Transition Period Ended: _________________
Nothing in this
form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
NuGene International, Inc.
Full Name of Registrant
Former Name if Applicable
17912 Cowan, Suite A
Address of Principal Executive Office
(Street and Number)
Irvine, California 92614
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check
box if appropriate)
x
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K,
20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time
period.
The Registrant is unable to file its annual
report on Form 10-Q within the prescribed time period because the Registrant requires additional time to finalize its financial
statements for review by its independent accountant.
PART IV — OTHER INFORMATION
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|
Keith A. Rosenbaum
|
949
|
851-4300
|
|
(Name)
|
(Area Code)
|
(Telephone Number)
|
(2)
|
Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding
12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify
report(s).
☒ Yes
☐ No
|
|
|
(3)
|
Is it anticipated that any significant change
in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to
be included in the subject report or portion thereof ?
☐
Yes ☒ No
If so, attach an explanation of the anticipated
change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot
be made.
|
NuGene International, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on
its behalf by the undersigned hereunto duly authorized.
Date: 14 November 2016
|
By:
|
/s/ M. Saeed Kharazmi
|
|
|
M. Saeed Kharazmi
|
|
Title:
|
CFO
|
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Apr 2023 to Apr 2024